In a significant development for Telangana’s life sciences and innovation sector, Eli Lilly, a renowned US pharmaceutical company, officially opened its Global Capability Center (GCC) in Hyderabad. Telangana’s Chief Minister, A Revanth Reddy, hailed this inauguration as a monumental achievement, positioning Hyderabad as the new global hub for GCCs. Reddy highlighted the state’s strategic vision and dedicated efforts, emphasizing how Hyderabad has evolved into a pivotal center for life sciences and pharmaceutical advancements over the last 20 months.
During the inauguration ceremony, CM Reddy outlined ambitious goals for the state, envisioning Hyderabad not only as the life sciences capital of India but also as the GCC capital of the world. By setting targets to achieve a $1 trillion economy by 2034 and contribute 10% to India’s $30 trillion economy by 2047, Telangana aims to solidify its position in the global economic landscape. The newly inaugurated 2.2 lakh sqft facility has already commenced operations with 100 professionals and plans to scale up its workforce to 1,500 in the coming years.
Expressing Eli Lilly’s commitment to India, Diogo Rau, the Executive Vice President and Chief Information and Digital Officer of Eli Lilly and Company, emphasized the long-term investment in the region. Hyderabad’s burgeoning reputation as a digital innovation hotspot was underscored by Sridhar Babu, IT Minister, who viewed the establishment of Lilly’s new site as a testament to the city’s technological advancement. With 70 GCCs inaugurated in Hyderabad during 2024–25, the region has set a national record, showcasing the pivotal role of technology in transforming healthcare.
Acknowledging the collaborative efforts that led to this milestone, the Chief Minister commended key officials such as Minister D Sridhar Babu, Special Chief Secretary Sanjay, IT and Industries Principal Secretary Jayesh Ranjan, and TSIIC MD Shakthi Nagappan for their contributions. He extended gratitude to Eli Lilly’s global leadership and the broader industry for their trust and continued investments in Telangana. The newly established center is poised to drive Lilly’s global operations, focusing on technological innovation and research to tackle critical healthcare challenges worldwide.
Key Takeaways:
– Eli Lilly’s establishment of a Global Capability Center in Hyderabad signifies a significant stride in the state’s life sciences and innovation sector.
– Telangana aims to position Hyderabad as the global capital for GCCs, with ambitious economic targets set for the future.
– The inauguration ceremony highlighted Hyderabad’s emergence as a digital innovation epicenter, with a record number of GCCs inaugurated in the region.
– The new Eli Lilly center is poised to spearhead global operations, emphasizing technological innovation to address pressing healthcare issues worldwide.
Read more on thehansindia.com